Advertisement
U.S. markets open in 6 hours 45 minutes

Seres Therapeutics, Inc. (MCRB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
1.0500+0.0100 (+0.96%)
At close: 04:00PM EST
1.0699 +0.02 (+1.90%)
After hours: 08:00PM EST
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
Total Revenue
127,236
7,128
144,927
33,215
Operating Expense
264,000
253,618
209,420
121,345
Operating Income
-136,764
-246,490
-64,493
-88,130
Net Non Operating Interest Income Expense
-4,283
-2,962
-40
-1,978
Other Income Expense
-225
-705
-1,045
981
Pretax Income
-141,272
-250,157
-65,578
-89,127
Net Income Common Stockholders
-141,272
-250,157
-65,578
-89,127
Diluted NI Available to Com Stockholders
-141,272
-250,157
-65,578
-89,127
Basic EPS
-1.11
-2.31
-0.72
-1.12
Diluted EPS
-1.11
-2.31
-0.72
-1.12
Basic Average Shares
126,765
108,077
91,703
79,789
Diluted Average Shares
126,765
108,077
91,703
79,789
Total Operating Income as Reported
-136,764
-246,490
-64,493
-88,130
Total Expenses
264,000
253,618
209,420
121,345
Net Income from Continuing & Discontinued Operation
-141,272
-250,157
-65,578
-89,127
Normalized Income
-141,272
-250,157
-65,578
-89,127
Interest Income
6,744
3,058
2,870
946
Interest Expense
11,027
6,020
2,910
2,924
Net Interest Income
-4,283
-2,962
-40
-1,978
EBIT
-130,245
-244,137
-62,668
-86,203
EBITDA
-124,007
-237,508
-56,721
-79,625
Reconciled Depreciation
6,238
6,629
5,947
6,578
Net Income from Continuing Operation Net Minority Interest
-141,272
-250,157
-65,578
-89,127
Total Unusual Items Excluding Goodwill
-
-
0
0
Total Unusual Items
-
-
0
0
Normalized EBITDA
-124,007
-237,508
-56,721
-79,625
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0